Virtual clinical trials : challenges and opportunities, proceedings of a workshop.
Successful drug development relies on accurate and efficient clinical trials to deliver the best and most effective pharmaceuticals and clinical care to patients. However, the current model for clinical trials is outdated, inefficient and costly. Clinical trials are limited by small sample sizes tha...
| Uniform Title: | Consensus study report.
|
|---|---|
| Corporate Authors: | |
| Other Authors: | |
| Language: | English |
| Published: |
Washington, D.C. :
National Academies Press,
2019.
|
| Series: | Consensus study report.
|
| Subjects: | |
| Physical Description: | xviii, 108 pages : charts ; 23 cm. |
| Format: | Book |
| Summary: |
Successful drug development relies on accurate and efficient clinical trials to deliver the best and most effective pharmaceuticals and clinical care to patients. However, the current model for clinical trials is outdated, inefficient and costly. Clinical trials are limited by small sample sizes that do not reflect variations among patients in the real world, financial burdens on participants, and slow processes, and these factors contribute to the disconnect between clinical research and clinical practice. On November 28-29, the National Academies of Sciences, Engineering, and Medicine convened a workshop to investigate the current clinical trials system and explore the potential benefits and challenges of implementing virtual clinical trials as an enhanced alternative for the future. This publication summarizes the presentations and discussions from the workshop.--Publishers website |
|---|---|
| Call Number: | RM301.27 .V57 2019 |
| Bibliography Note: | Includes bibliographical references. |
| ISBN: | 0309494885 9780309494885 9780309494892 0309494893 9780309494915 0309494915 |
| Action Note: |
copy1 Committed to retain 20200101 20341231 MI-SPI http://www.mcls.org/engagement/mi-spi/ MiEM |